Fig. 1From: Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: the GOMAP studyStudy participant flow diagram. SCZ: schizophrenia, BD: bipolar disorder, MDD: major depressive disorder, T2D: type 2 diabetesBack to article page